Moderna completes enrollment in large COVID-19 vaccine study

07:05 Fri, 24 September

GEO

USD

$ 0.0000

EUR

€ 0.0000

GBP

£ 0.0000

RUB

₽ 0.0000

TRY

₺ 0.0000

AZN

₼ 0.0000

Bitcoin

44,420.1000

Ethereum

3,100.8200

Bitchoin Cash

544.4390

Litecoin

161.9080

XRP

0.9890

22.Oct .2020 22:00

Moderna completes enrollment in large COVID-19 vaccine study

242

Back

Moderna Inc said it had completed the enrollment of 30,000 participants in a late-stage study testing its experimental coronavirus vaccine, with over a third of the participants from communities of color – Reuters reports.

Over 25,650 participants have so far received their second shot of the vaccine candidate, mRNA-1273 – Reuters quotes the company.

The U.S. Food and Drug Administration requires at least two months of safety data after a full vaccination regime to review applications for emergency use authorization of an experimental vaccine.

Modern Medical Solution